TCL Archive CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome April 22, 1983
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013